Skip to main content

Pharmacy

By Susan Morse | 07:48 pm | February 10, 2022
The Eli Lilly drug awaits emergency use authorization from the FDA.
By Jeff Lagasse | 04:47 pm | February 09, 2022
SD Biosensor said it has initiated an investigation to determine how the product was illegally imported into the U.S.
By Susan Morse | 11:49 am | February 09, 2022
The money is going to eight community organizations serving underserved areas to boost vaccine confidence.
By Susan Morse | 10:48 am | February 04, 2022
Legislation could permit insurers to base payment for COVID-19 tests administered out-of-network on their median in-network rate, AHIP says.
By Jeff Lagasse | 05:03 pm | February 03, 2022
Meanwhile, 29% of such parents said they'll take a wait-and-see approach, while 12% said they'd do it only if it was required.
By Susan Morse | 11:07 am | February 03, 2022
The tests are expected to become available in early spring for those on original Medicare or in a Medicare Advantage plan.
By Susan Morse | 04:06 pm | February 02, 2022
The COVID-19 vaccine would be the first available to help protect children under 5 years of age.
By Susan Morse | 05:46 pm | February 01, 2022
In a separate Blue Cross settlement, Shkreli's companies will pay $28 million, which will be given to third-party payers.
By Susan Morse | 11:23 am | February 01, 2022
The vaccine is being marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age and older.
By Jeff Lagasse | 12:41 pm | January 27, 2022
Bamlanivimab and etesevimab, which are administered in tandem, and REGEN-COV are not effective against Omicron, the FDA said.